Simon Cleall
University of Copenhagen · 25 works · 2,765 citations · h-index 10
Top works
- Gemcitabine and Cisplatin Versus Methotrexate, Vinblastine, Doxorubicin, and Cisplatin in Advanced or Metastatic Bladder Cancer: Results of a Large, Randomized, Multinational, Multicenter, Phase III Study
- Glucagon-Like Peptide 1 Receptor Agonist or Bolus Insulin With Optimized Basal Insulin in Type 2 Diabetes
- Clinical outcomes after 24 months of insulin therapy in patients with type 2 diabetes in five countries: results from the TREAT study
- Insulin lispro low mixture twice daily versus basal insulin glargine once daily and prandial insulin lispro once daily in patients with type 2 diabetes requiring insulin intensification: a randomized phase IV trial
- Decision-making in a phase II clinical trial: a new approach combining Bayesian and frequentist concepts
- Gemcitabine and Cisplatin Versus Methotrexate, Vinblastine, Doxorubicin, and Cisplatin in Advanced or Metastatic Bladder Cancer: Results of a Large, Randomized, Multinational, Multicenter, Phase III Study
- Impact of Conversation Map™ Education Tools Versus Regular Care on Diabetes-Related Knowledge of People With Type 2 Diabetes: A Randomized, Controlled Study
- 1.6 Exenatide BID vs. Insulin Lispro TIDM Added to Titrated Insulin Glargine QD in Metformin-Treated T2DM Patients Resulted in Similar Glycemic Control but Weight Loss and Less Hypoglycemia: The 4B Study (70-OR)
- Impacto de las herramientas «Mapas de Conversaciones™» sobre el conocimiento de la diabetes en pacientes españoles con diabetes mellitus tipo 2: un estudio aleatorizado y comparativo
- Impact of “Conversation Map™” tools on understanding of diabetes by Spanish patients with type 2 diabetes mellitus: A randomized, comparative study
- Comparison of 3 sequential treatment regimens of teriparatide: Final results from the EUROFORS study
- Comparison of insulin lispro protamine suspension versus insulin glargine once daily in basal‐bolus therapies with insulin lispro in type 2 diabetes patients: a prospective randomized open‐label trial
- Population Pharmacokinetics of Vixotrigine in Healthy Volunteers and Subjects with Trigeminal Neuralgia, Painful Lumbosacral Radiculopathy and Erythromelalgia
- Resource utilisation and clinical data before and after switching between short-acting human insulin and rapid-acting insulin analogues in patients with type 2 diabetes: The SWING study
- Insulin Titration – Gaining an Understanding of the Burden of Type 2 Diabetes in Europe (INSTIGATE Study): Behandlungspfade mit oralen Antidiabetika vor Umstellung auf Insulin und Auswahl der Insulintherapie-Regime
- Modelling Survival Data in Medical Research (second edition) Collett D (2003) ISBN 1584883251; 408 pages; CRC Press; http://www.crcpress.com/shopping_cart/products/product_detail.asp?sku=C3251
- Efficacy and safety of a premixed versus a basal-plus insulin regimen as intensification for type 2 diabetes by timing of the main meal
- PO133 INSULIN LISPRO MIX 25/75 TWICE DAILY (LM25 BID) VS BASAL INSULIN GLARGINE + PRANDIAL INSULIN LISPRO BOTH ONCE DAILY (IGL) IN TYPE 2 DIABETES (T2D): ANALYSIS BASED ON THE MAIN MEAL
- Insulin lispro low mixture twice daily versus basal insulin glargine once daily and prandial insulin lispro once daily in patients with type 2 diabetes mellitus requiring insulin intensification—a randomized phase IV trial: Indian subpopulation analyses
- Glycaemic control and hypoglycaemia in metformin-treated T2DM patients with exenatide BID vs insulin lispro TID added to titrated insulin glargine QD: the 4B trial